ziprasidone hydrochloride

Product NDC
70518-2366
11-digit product format
705182366
Labeler code
70518
Product ID
70518-2366_c895d928-7677-80ea-e053-2995a90aa2c4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ziprasidone hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA077562
Marketing category
ANDA
Marketing start
2019-10-17
Marketing end
0000-00-00
Substance
ZIPRASIDONE HYDROCHLORIDE
Active strength
80 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2366-02023-03-09C16284748780-1f386c649-ae7c-0266-e053-dadaa90a7c1a006c9a3a-1527-4b89-a883-ff250dafa7de
70518-2366-02023-01-30C16284748780-1f386c649-ae7c-0266-e053-dadaa90a7c1a006c9a3a-1527-4b89-a883-ff250dafa7de

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2366-07051823660030 POUCH in 1 BOX, UNIT-DOSE (70518-2366-0) > 1 CAPSULE in 1 POUCH (70518-2366-1) 30 pouch2019-10-170000-00-00NoNoCurrent